Hyperuricemia and cardiovascular risk: gut microbiota as a key link in pathogenesis and a new target for therapy
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Hyperuricemia is a significant and independent risk factor for cardiovascular diseases. In recent years, scientists have been paying attention to the gut microbiota and its impact on various processes in the human body. Currently, there is evidence of the important role of the microbiota in the pathogenesis of hyperuricemia. An increase in the number of pathogenic microflora contributes to chronic inflammation and an increase in uric acid levels through the mechanisms of purine metabolism. The purpose of this review is to analyze and systematize current data on the impact of the intestinal microbiota on the pathogenesis of hyperuricemia and cardiovascular risk. The article discusses promising methods for correcting hyperuricemia, such as lifestyle modification, fecal microbiota transplantation, probiotics, and postbiotics. The review highlights the need for further research on the microbiota as a key factor in the pathogenesis of hyperuricemia and the development of new and innovative therapeutic strategies.
Fields of Study & Subjects
Gout
Hyperuricemia
Uric Acid
Gut microbiota and health
Diet
Metabolism
and Disease
Publication details
- Journal / source
- The Russian Archives of Internal Medicine
- Volume
- 16
- Issue
- 2
- Pages
- 104–112
- Publication date
- 28 March 2026
- Language
- EN